An exploration of the clinical progression models of osimertinib in the treatment of advanced EGFR-mutant non-small cell lung cancer.
Translational lung cancer research（2022）
关键词
Osimertinib,epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI),non-small cell lung cancer (NSCLC),progression models,targeted therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要